J&J Reports Higher-Than-Expected Profit as Medical Device Sales Face Middle East Drag

Johnson & Johnson reported a slightly higher-than-expected third-quarter profit, citing strong sales of Tremfya and a drag on its medical devices business from geopolitical issues including the Middle East conflict.